文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

出版信息

Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.


DOI:10.1016/S0140-6736(17)32130-X
PMID:28919118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5605707/
Abstract

BACKGROUND: Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: disability-adjusted life-years (DALYs) and healthy life expectancy (HALE). We used these measures to track trends and benchmark progress compared with expected trends on the basis of the Socio-demographic Index (SDI). METHODS: We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2016. We calculated DALYs by summing years of life lost and years of life lived with disability for each location, age group, sex, and year. We estimated HALE using age-specific death rates and years of life lived with disability per capita. We explored how DALYs and HALE differed from expected trends when compared with the SDI: the geometric mean of income per person, educational attainment in the population older than age 15 years, and total fertility rate. FINDINGS: The highest globally observed HALE at birth for both women and men was in Singapore, at 75·2 years (95% uncertainty interval 71·9-78·6) for females and 72·0 years (68·8-75·1) for males. The lowest for females was in the Central African Republic (45·6 years [42·0-49·5]) and for males was in Lesotho (41·5 years [39·0-44·0]). From 1990 to 2016, global HALE increased by an average of 6·24 years (5·97-6·48) for both sexes combined. Global HALE increased by 6·04 years (5·74-6·27) for males and 6·49 years (6·08-6·77) for females, whereas HALE at age 65 years increased by 1·78 years (1·61-1·93) for males and 1·96 years (1·69-2·13) for females. Total global DALYs remained largely unchanged from 1990 to 2016 (-2·3% [-5·9 to 0·9]), with decreases in communicable, maternal, neonatal, and nutritional (CMNN) disease DALYs offset by increased DALYs due to non-communicable diseases (NCDs). The exemplars, calculated as the five lowest ratios of observed to expected age-standardised DALY rates in 2016, were Nicaragua, Costa Rica, the Maldives, Peru, and Israel. The leading three causes of DALYs globally were ischaemic heart disease, cerebrovascular disease, and lower respiratory infections, comprising 16·1% of all DALYs. Total DALYs and age-standardised DALY rates due to most CMNN causes decreased from 1990 to 2016. Conversely, the total DALY burden rose for most NCDs; however, age-standardised DALY rates due to NCDs declined globally. INTERPRETATION: At a global level, DALYs and HALE continue to show improvements. At the same time, we observe that many populations are facing growing functional health loss. Rising SDI was associated with increases in cumulative years of life lived with disability and decreases in CMNN DALYs offset by increased NCD DALYs. Relative compression of morbidity highlights the importance of continued health interventions, which has changed in most locations in pace with the gross domestic product per person, education, and family planning. The analysis of DALYs and HALE and their relationship to SDI represents a robust framework with which to benchmark location-specific health performance. Country-specific drivers of disease burden, particularly for causes with higher-than-expected DALYs, should inform health policies, health system improvement initiatives, targeted prevention efforts, and development assistance for health, including financial and research investments for all countries, regardless of their level of sociodemographic development. The presence of countries that substantially outperform others suggests the need for increased scrutiny for proven examples of best practices, which can help to extend gains, whereas the presence of underperforming countries suggests the need for devotion of extra attention to health systems that need more robust support. FUNDING: Bill & Melinda Gates Foundation.

摘要

背景:衡量不同地点的健康变化有助于比较和对比不断变化的流行病学模式与卫生系统绩效,并确定在研究、政策制定和规划决策中资源分配的具体需求。我们利用全球疾病、伤害和危险因素研究 2016 年的数据,从两个广泛使用的综合指标中提取数据,以监测人口健康方面的此类变化:伤残调整生命年(DALYs)和健康期望寿命(HALE)。我们使用这些指标来跟踪趋势,并根据社会人口指数(SDI)的预期趋势进行基准比较。

方法:我们利用全球疾病、伤害和危险因素研究 2016 年的所有原因死亡率、特定原因死亡率和非致命性疾病负担的数据,为 195 个国家和地区计算了 1990 年至 2016 年期间的两性 DALY 和 HALE。我们通过为每个地点、年龄组、性别和年份计算失去的生命年和残疾生活的生命年来计算 DALY。我们使用特定年龄的死亡率和人均残疾生活年数来估计 HALE。我们探讨了 DALY 和 HALE 与 SDI 相比如何出现偏离预期的情况:SDI 是指人均收入、15 岁以上人口的教育程度和总生育率的几何平均值。

结果:全球范围内女性和男性的出生时 HALE 最高的是新加坡,分别为 75.2 岁(95%不确定区间为 71.9-78.6)和 72.0 岁(68.8-75.1)。女性中最低的是中非共和国(45.6 岁[42.0-49.5]),男性中最低的是莱索托(41.5 岁[39.0-44.0])。1990 年至 2016 年期间,全球 HALE 平均增长了 6.24 岁(5.97-6.48),两性均有所增加。男性 HALE 增长了 6.04 岁(5.74-6.27),女性增长了 6.49 岁(6.08-6.77),而 65 岁时的 HALE 男性增长了 1.78 岁(1.61-1.93),女性增长了 1.96 岁(1.69-2.13)。1990 年至 2016 年期间,全球 DALY 总数基本保持不变(-2.3%[-5.9 至 0.9]),传染性疾病、孕产妇、新生儿和营养(CMNN)疾病的 DALY 减少被非传染性疾病(NCD)的 DALY 增加所抵消。以 2016 年观察到的年龄标准化 DALY 率与预期比率最低的五个比值为代表的例子是尼加拉瓜、哥斯达黎加、马尔代夫、秘鲁和以色列。全球 DALY 排名前三位的原因是缺血性心脏病、脑血管病和下呼吸道感染,占所有 DALY 的 16.1%。1990 年至 2016 年期间,CMNN 大多数病因的 DALY 总数和年龄标准化 DALY 率下降。相反,大多数 NCD 的 DALY 总负担上升;然而,全球 NCD 的年龄标准化 DALY 率下降。

解释:在全球范围内,DALY 和 HALE 继续显示出改善。与此同时,我们观察到许多人群正面临着日益严重的功能健康损失。随着 SDI 的上升,累积的残疾生活年数增加,CMNN 的 DALY 减少被 NCD 的 DALY 增加所抵消。发病率的相对压缩突出了继续进行健康干预的重要性,这在大多数地方都随着人均国内生产总值、教育和计划生育而变化。DALY 和 HALE 及其与 SDI 的关系的分析代表了一个稳健的框架,可以对特定地点的健康绩效进行基准比较。疾病负担的特定驱动因素,特别是那些 DALY 高于预期的原因,应该为卫生政策、卫生系统改进举措、有针对性的预防工作以及包括所有国家在内的卫生发展援助提供信息,无论其社会人口发展水平如何。存在表现明显优于其他国家的国家表明,需要对经过验证的最佳实践进行更严格的审查,以帮助扩大收益,而存在表现不佳的国家则表明需要更加关注需要更有力支持的卫生系统。

资金:比尔及梅琳达·盖茨基金会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/bdc45b970272/gr8a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/4efb16b31182/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/cd3a6ee92ff7/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/5992d8701487/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/389ba1e1e582/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/cc3320a9abba/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/d20cda3fe716/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/6c99d8c8454c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/bdc45b970272/gr8a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/4efb16b31182/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/cd3a6ee92ff7/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/5992d8701487/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/389ba1e1e582/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/cc3320a9abba/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/d20cda3fe716/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/6c99d8c8454c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34d/5605707/bdc45b970272/gr8a.jpg

相似文献

[1]
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[2]
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet. 2016-10-8

[3]
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-10

[4]
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[5]
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.

Lancet. 2015-11-28

[6]
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[7]
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[8]
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-12-7

[9]
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[10]
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet. 2016-10-8

引用本文的文献

[1]
Economic evaluation of financial incentives for maternal and child health in the Democratic Republic of the Congo (DRC): a decision-tree modelling based on a cluster randomized controlled trial.

Glob Health Res Policy. 2025-9-1

[2]
A machine learning approach to predict positive coronary artery calcium scores in individuals with diabetes: a cross-sectional analysis of ELSA-Brasil baseline data.

Braz J Med Biol Res. 2025-8-22

[3]
Association between the estimated glucose disposal rate and the occurrence of major cardiovascular events and stroke.

Diabetol Metab Syndr. 2025-8-4

[4]
Water, sanitation, and hygiene (WASH) factors and the incidence of communicable diseases in Urban Bangladesh: Evidence from municipal areas.

PLoS Negl Trop Dis. 2025-7-31

[5]
Association of low knowledge about cardiovascular disease and lack of lifestyle changes after the COVID-19 pandemic with higher cardiovascular risk in Peruvian residents.

J Public Health Res. 2025-7-23

[6]
Genes linked to schistosome resistance identified in a genome-wide association study of African snail vectors.

Nat Commun. 2025-7-27

[7]
Bitter Taste Receptors in Bacterial Infections and Innate Immunity.

Immun Inflamm Dis. 2025-7

[8]
Addressing treatment fatigue, therapeutic inertia, and cognitive dissonance in musculoskeletal pain management in primary care setting.

Front Med (Lausanne). 2025-6-25

[9]
Protective Mechanisms of EGCG in Mitigating Oxidative Stress and Liver Toxicity From Cigarette Smoke-Induced Damage.

Food Sci Nutr. 2025-7-7

[10]
Genetic liability to major psychiatric disorders contributes to multi-faceted quality of life outcomes in children and adults.

Transl Psychiatry. 2025-7-7

本文引用的文献

[1]
Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development Goals.

Lancet. 2017-9-25

[2]
Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys.

World Psychiatry. 2017-10

[3]
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[4]
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[5]
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[6]
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[7]
Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990-2015.

Int J Public Health. 2017-8-3

[8]
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.

Lancet. 2017-7-15

[9]
Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.

Lancet. 2017-4-19

[10]
Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.

Lancet. 2017-4-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索